Philip Ferneau insider trades

Open-market stock purchases and sales by Philip Ferneau, Director at Compass Therapeutics, Inc, from SEC Form 4 filings since Jun 19, 2020.

Recent trades

DateStockTradeValue
Jan 2, 2026CMPX Compass Therapeutics, IncBought (not open market)—

Companies traded

  • CMPX Compass Therapeutics, Inc: other filings, last Jan 2, 2026

Get free alerts when Philip Ferneau files a new trade →